WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013115746) A PRODUCTION METHOD FOR (EFFERVESCENT) PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR (MIGLITOL) AND METFORMIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/115746    International Application No.:    PCT/TR2013/000055
Publication Date: 08.08.2013 International Filing Date: 31.01.2013
IPC:
A61K 31/155 (2006.01), A61K 31/455 (2006.01), A61K 45/06 (2006.01), A61K 9/16 (2006.01), A61K 9/20 (2006.01), A61K 9/46 (2006.01), A61K 47/02 (2006.01), A61K 47/32 (2006.01), A61K 47/36 (2006.01), A61K 47/38 (2006.01), A61K 47/42 (2006.01)
Applicants: BILGIC, Mahmut [TR/TR]; (TR)
Inventors: BILGIC, Mahmut; (TR)
Agent: GOKDEMIR, Burcu; Yildiz Teknik Univ. Davutpasa Kampusu Teknopark Alani D Blok Esenler Istanbul (TR)
Priority Data:
2012/01094 31.01.2012 TR
2012/03399 26.03.2012 TR
Title (EN) A PRODUCTION METHOD FOR (EFFERVESCENT) PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR (MIGLITOL) AND METFORMIN
(FR) PROCÉDÉ DE PRÉPARATION DE COMPOSITIONS PHARMACEUTIQUES (EFFERVESCENTES) CONTENANT UN INHIBITEUR DE L'APHA-GLUCOSIDASE (MIGLITOL) ET DE LA METFORMINE
Abstract: front page image
(EN)The present invention relates to a process used in production of the effervescent formulations comprising the alpha-glucosidase inhibitor miglitol and metformin as the active agent that shall be used in improving glycemic control in adults suffering from non-insulin dependent diabetes (type 2) wherein hyperglycaemia cannot be controlled by diet or exercise.
(FR)La présente invention porte sur un procédé utilisé pour la préparation de formulations effervescentes qui contiennent en tant que principe actif l'inhibiteur de l'alpha-glucosidase miglitol et de la metformine, et qui sont destinées à être utilisées pour améliorer la régulation de la glycémie chez les adultes souffrant de diabète non insulinodépendant (type 2), lorsque l'hyperglycémie ne peut être régulée par un régime alimentaire ou l'exercice physique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)